Carregant...

Transitioning from parenteral treprostinil to inhaled treprostinil in patients with pulmonary arterial hypertension

Treprostinil is a potent prostacyclin vasodilator indicated for the treatment of pulmonary arterial hypertension (PAH, World Health Organization Group I). Previously, treprostinil was available only in subcutaneous (SC) or intravenous (IV) formulations. Availability of an inhaled formulation of trep...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Raina, Amresh, Coons, James C., Kanwar, Manreet, Murali, Srinivas, Sokos, George, Benza, Raymond L.
Format: Artigo
Idioma:Inglês
Publicat: Medknow Publications 2013
Matèries:
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3641714/
https://ncbi.nlm.nih.gov/pubmed/23662183
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4103/2045-8932.109926
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!